{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:56:28Z","timestamp":1786982188195,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T00:00:00Z","timestamp":1614643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T00:00:00Z","timestamp":1614643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s12020-021-02629-w","type":"journal-article","created":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T14:02:59Z","timestamp":1614693779000},"page":"553-561","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Canadian national hypoparathyroidism registry: an overview of hypoparathyroidism in Canada"],"prefix":"10.1007","volume":"72","author":[{"given":"Aliya A.","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajar","family":"AbuAlrob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zubin","family":"Punthakee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Shrayyef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafik El","family":"Werfalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisham Al","family":"Kassem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoela","family":"Braga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Millar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharjil","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayyab","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terri","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stan","family":"Van Uum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Edward Massey","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,2]]},"reference":[{"issue":"3","key":"2629_CR1","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1530\/EJE-18-0609","volume":"180","author":"AA Khan","year":"2019","unstructured":"A.A. Khan, C. Koch, S.H.M. Van Uum, J.P. Baillargeon, J. Bollerslev, M.L. Brandi, C. Marcocci, L. Rejnmark, R. Rizzoli, M.Z. Shrayyef, R.V. Thakker, B.O. Yildiz, B. Clarke, Standards of Care for Hypoparathyroidism in Adults. Eur. J. Endocrinol. 180(3), P1\u2013P22 (2019)","journal-title":"Eur. J. Endocrinol."},{"key":"2629_CR2","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1210\/jc.2015-3907","volume":"101","author":"ML Brandi","year":"2016","unstructured":"M.L. Brandi, J.P. Bilezikian, D. Shoback, R. Bouillon, B.L. Clarke, R.V. Thakker, A.A. Khan, J.T. Potts, Management of hypoparathyroidism: summary statement and guidelines. J. Clin. Endocrinol. Metab. 101, 2273\u20132283 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2629_CR3","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.beem.2012.01.004","volume":"26","author":"H Al-Azem","year":"2012","unstructured":"H. Al-Azem, A.A. Khan, Hypoparathyroidism. Best Pract. Res: Clin. Endocrinol. Metab. 26, 517\u2013522 (2012)","journal-title":"Best Pract. Res: Clin. Endocrinol. Metab."},{"issue":"10","key":"2629_CR4","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1002\/jbmr.483","volume":"26","author":"JP Bilezikian","year":"2011","unstructured":"J.P. Bilezikian, A. Khan, J.T. Potts Jr, M.L. Brandi, B.L. Clarke, D. Shoback, H. J\u00fcppner, P. D\u2019Amour, J. Fox, L. Rejnmark, L. Mosekilde, M.R. Rubin, D. Dempster, R. Gafni, M.T. Collins, J. Sliney, J. Sanders, Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J. Bone Miner. Res. 26(10), 2317\u20132337 (2011)","journal-title":"J. Bone Miner. Res."},{"key":"2629_CR5","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1056\/NEJMcp0803050","volume":"359","author":"D Shoback","year":"2008","unstructured":"D. Shoback, Clinical practice. Hypoparathyroidism. N. Engl. J Med. 359, 391\u2013403 (2008)","journal-title":"N. Engl. J Med."},{"key":"2629_CR6","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1210\/jc.2015-3909","volume":"101","author":"DM Shoback","year":"2016","unstructured":"D.M. Shoback, J.P. Bilezikian, A.G. Costa, D. Dempster, H. Dralle, A.A. Khan, R.Bouillon, Presentation of hypoparathyroidism: etiologies and clinical features. J. Clin. Endocrinol. Metab. 101, 2300\u20132312 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2629_CR7","doi-asserted-by":"publisher","first-page":"17055","DOI":"10.1038\/nrdp.2017.55","volume":"3","author":"M Mannstadt","year":"2017","unstructured":"M. Mannstadt, J.P. Bilezikian, R.V. Thakker, F.M. Hannan, B.L. Clarke, L. Rejnmark, D.M. Shoback, Hypoparathyroidism. Nat. Rev. Dis. Primers 3, 17055 (2017)","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"12","key":"2629_CR8","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1002\/jbmr.2004","volume":"28","author":"J Powers","year":"2013","unstructured":"J. Powers, K. Joy, A. Ruscio, H. Lagast, Prevalence and incidence of hypoparathyroidism in the United States using a large claims database. J. Bone Miner. Res. 28(12), 2570\u20132576 (2013)","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"2629_CR9","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/jbmr.3368","volume":"33","author":"L Underbjerg","year":"2018","unstructured":"L. Underbjerg, T. Sikjaer, L. Rejnmark, Long-Term Complications in Patients With Hypoparathyroidism Evaluated by Biochemical Findings: a Case-Control Study. J. Bone Miner. Res. 33(5), 822\u2013831 (2018).","journal-title":"J. Bone Miner. Res."},{"key":"2629_CR10","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.1210\/jc.2012-1808","volume":"97","author":"DM Mitchell","year":"2012","unstructured":"D.M. Mitchell, S. Regan, M.R. Cooley, K.B. Lauter, M.C. Vrla, C.B. Becker, M. Mannstadt, Long-term follow-up of patients with hypoparathyroidism. J. Clin. Endocrinol. Metab. 97, 4507\u20134514 (2012)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2629_CR11","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1002\/jbmr.1979","volume":"28","author":"L Underbjerg","year":"2013","unstructured":"L. Underbjerg, T. Sikjaer, L. Mosekilde, L. Rejnmark, Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J. Bone Miner. Res. 28, 2277\u20132285 (2013)","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"2629_CR12","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1210\/jc.2015-3908","volume":"101","author":"BL Clarke","year":"2016","unstructured":"B.L. Clarke, E.M. Brown, M.T. Collins, H. J\u00fcppner, P. Lakatos, M.A. Levine, M.M. Mannstadt, J.P. Bilezikian, A.F. Romanischen, R.V. Thakker, Epidemiology and Diagnosis of Hypoparathyroidism. J. Clin. Endocrinol. Metab. 101(6), 2284\u20132299 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"2629_CR13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/cen.13895","volume":"90","author":"T Vadiveloo","year":"2019","unstructured":"T. Vadiveloo, P.T. Donnan, C.J. Leese, K.J. Abraham, G.P. Leese, Increased mortality and morbidity in patients with chronic hypoparathyroidism: a population-based study. Clin. Endocrinol. (Oxf) 90(2), 285\u2013292 (2019)","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"2","key":"2629_CR14","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jocd.2007.01.001","volume":"10","author":"K Siminoski","year":"2007","unstructured":"K. Siminoski, W.D. Leslie, H. Frame, A. Hodsman, R.G. Josse, A. Khan, B.C. Lentle, J. Levesque, D.J. Lyons, G. Tarulli, J.P. Brown, Recommendations for bone mineral density reporting in Canada: a shift to absolute fracture risk assessment. J. Clin. Densitom. 10(2), 120\u2013123 (2007)","journal-title":"J. Clin. Densitom."},{"issue":"4","key":"2629_CR15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.carj.2011.05.001","volume":"62","author":"B Lentle","year":"2011","unstructured":"B. Lentle, A.M. Cheung, D.A. Hanley, W.D. Leslie, D. Lyons, A. Papaioannou, S. Atkinson, J.P. Brown, S. Feldman, A.B. Hodsman, A.S. Jamal, R.G. Josse, S.M. Kaiser, B. Kvern, S. Morin, K. Siminoski, Scientific Advisory Council of Osteoporosis Canada. Osteoporosis Canada 2010 guidelines for the assessment of fracture risk. Can. Assoc. Radiol. J. 62(4), 243\u2013250 (2011)","journal-title":"Can. Assoc. Radiol. J."},{"issue":"2","key":"2629_CR16","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1006\/cimm.1993.1245","volume":"151","author":"Y Abu-Amer","year":"1993","unstructured":"Y. Abu-Amer, Z. Bar-Shavit, Impaired bone marrow-derived macrophage differentiation in vitamin D deficiency. Cell Immunol. 151(2), 356\u2013368 (1993)","journal-title":"Cell Immunol."},{"key":"2629_CR17","doi-asserted-by":"publisher","first-page":"101295","DOI":"10.1016\/j.redox.2019.101295","volume":"26","author":"C Cui","year":"2019","unstructured":"C. Cui, P. Xu, G. Li, Y. Qiao, W. Han, C. Geng, D. Liao, M. Yang, D. Chen, P. Jiang, Vitamin D receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial cells: role of renin-angiotensin system. Redox. Biol. 26, 101295 (2019 Sep)","journal-title":"Redox. Biol."},{"issue":"12","key":"2629_CR18","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1359\/jbmr.080803","volume":"23","author":"MR Rubin","year":"2008","unstructured":"M.R. Rubin, D.W. Dempster, H. Zhou, E. Shane, T. Nickolas, J. Sliney Jr, S.J. Silverberg, J.P. Bilezikian, Dynamic and structural properties of the skeleton in hypoparathyroidism. J. Bone Miner. Res. 23(12), 2018\u20132024 (2008)","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"2629_CR19","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.1365-2265.2012.04353.x","volume":"77","author":"R Goswami","year":"2012","unstructured":"R. Goswami, R. Sharma, V. Sreenivas, N. Gupta, A. Ganapathy, S. Das, Prevalence and progression of basal ganglia calcification and its pathogenic mechanism in patients with idiopathic hypoparathyroidism. Clin. Endocrinol. (Oxf). 77(2), 200\u2013206 (2012)","journal-title":"Clin. Endocrinol. (Oxf)."},{"issue":"2","key":"2629_CR20","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-15-0628","volume":"173","author":"J Bollerslev","year":"2015","unstructured":"J. Bollerslev, L. Rejnmark, C. Marcocci, D.M. Shoback, A. Sitges-Serra, W. Van Biesen, O.M. Dekkers, European Society of Endocrinology clinical guideline: treatment of chronic hypoparathyroidism in adults. Eur. J. Endocrinol. 173(2), G1\u201320 (2015)","journal-title":"Eur. J. Endocrinol."},{"key":"2629_CR21","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1210\/jc.2015-3910","volume":"101","author":"JP Bilezikian","year":"2016","unstructured":"J.P. Bilezikian, M.L. Brandi, N.E. Cusano, M. Mannstadt, L. Rejnmark, R. Rizzoli, J.T. Potts, Management of hypoparathyroidism: Present and future. J. Clin. Endocrinol. Metab. 101, 2313\u20132324 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2629_CR22","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1210\/jc.2015-4135","volume":"101","author":"MR Rubin","year":"2016","unstructured":"M.R. Rubin, N.E. Cusano, W.W. Fan, Y. Delgado, C. Zhang, A.G. Costa, S. Cremer, E. Dworakowski, J.P. Bilezikian, Therapy of hypoparathyroidism with PTH (1\u201384): a prospective six year investigation of efficacy and safety. J. Clin. Endocrinol. Metab. 101, 2742\u20132750 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2629_CR23","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.bone.2018.11.012","volume":"120","author":"MR Rubin","year":"2019","unstructured":"M.R. Rubin, Skeletal Manifestations of Hypoparathyroidism. Bone. 120, 548\u2013555 (2019)","journal-title":"Bone."},{"issue":"2","key":"2629_CR24","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/jbmr.2609","volume":"31","author":"NE Cusano","year":"2016","unstructured":"N.E. Cusano, K.K. Nishiyama, C. Zhang, M.R. Rubin, S. Boutroy, D.J. McMahon, X.E. Guo, J.P. Bilezikian, Noninvasive Assessment of Skeletal Microstructure and Estimated Bone Strength in Hypoparathyroidism. J. Bone Miner. Res. 31(2), 308\u2013316 (2016)","journal-title":"J. Bone Miner. Res."},{"issue":"11","key":"2629_CR25","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1002\/jbmr.2273","volume":"29","author":"L Underbjerg","year":"2014","unstructured":"L. Underbjerg, T. Sikjaer, L. Mosekilde, L. Rejnmark, Postsurgical hypoparathyroidism-risk of fractures, psychiatric diseases, cancer, cataract, and infections. J. Bone Miner. Res. 29(11), 2504\u20132510 (2014)","journal-title":"J. Bone Miner. Res."},{"key":"2629_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6823-13-1","volume":"13","author":"ML Mendon\u00e7a","year":"2013","unstructured":"M.L. Mendon\u00e7a, F.A. Pereira, M.H. Nogueira-Barbosa, L.M. Monsignore, S.R. Teixeira, P.C. Watanabe, L.M. Maciel, F.J. de Paula, Increased vertebral morphometric fracture in patients with postsurgical hypoparathyroidism despite normal bone mineral density. BMC Endocr. Disord. 13, 1 (2013)","journal-title":"BMC Endocr. Disord."},{"issue":"1","key":"2629_CR27","first-page":"251","volume":"102","author":"H Chawla","year":"2017","unstructured":"H. Chawla, S. Saha, D. Kandasamy, R. Sharma, V. Sreenivas, R. Goswami, Vertebral Fractures and Bone Mineral Density in Patients With Idiopathic Hypoparathyroidism on Long-Term Follow-Up. J. Clin. Endocrinol. Metab. 102(1), 251\u2013258 (2017)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2629_CR28","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1002\/jbmr.470","volume":"26","author":"T Sikjaer","year":"2011","unstructured":"T. Sikjaer, L. Rejnmark, L. Rolighed, L. Heickendorff, L. Mosekilde, The effect of adding PTH (1\u201384) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study. J. Bone Miner. Res. 26, 2358\u20132370 (2011)","journal-title":"J. Bone Miner. Res."},{"key":"2629_CR29","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s00198-014-2677-6","volume":"25","author":"T Sikjaer","year":"2014","unstructured":"T. Sikjaer, L. Rolighed, A. Hess, A. Fuglsang-Frederiksen, L. Mosekilde, L. Rejnmark, Effects of PTH(1\u201384) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial. Osteoporos. Int. 25, 1717 (2014)","journal-title":"Osteoporos. Int."},{"issue":"4","key":"2629_CR30","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S2213-8587(13)70106-2","volume":"1","author":"M Mannstadt","year":"2013","unstructured":"M. Mannstadt, B.L. Clarke, T. Vokes, M.L. Brandi, L. Ranganath, W.D. Fraser, P. Lakatos, L. Bajnok, R. Garceau, L. Mosekilde, H. Lagast, D. Shoback, J.P. Bilezikian, Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study. Lancet Diabetes Endocrinol. 1(4), 275\u2013283 (2013)","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"2","key":"2629_CR31","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1210\/jc.2017-01471","volume":"103","author":"TJ Vokes","year":"2018","unstructured":"T.J. Vokes, M. Mannstadt, M.A. Levine, B.L. Clarke, P. Lakatos, K. Chen, R. Piccolo, A. Krasner, D.M. Shoback, J.P. Bilezikian, Recombinant Human Parathyroid Hormone Effect on Health-Related Quality of Life in Adults With Chronic Hypoparathyroidism. J. Clin. Endocrinol. Metab. 103(2), 722\u2013731 (2018)","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02629-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-021-02629-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02629-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T06:21:13Z","timestamp":1621232473000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-021-02629-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["2629"],"URL":"https:\/\/doi.org\/10.1007\/s12020-021-02629-w","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,2]]},"assertion":[{"value":"18 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The ethical approval for the present study was obtained from the Hamilton Integrated Research Ethics Board HiREB (Project No: 14-664-D).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all participants per GCP guidelines.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}